Toronto Dominion Bank’s PTC Therapeutics PTCT Stock Holding History

Toronto Dominion Bank’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$177M	Sell	2,165,846 -860,117	-28%	-$62.1M	0.2%	96
2026 Q1	$206M	Sell	3,025,963 -1,112,252	-27%	-$78.8M	0.3%	60
2025 Q4	$314M	Buy	4,138,215 +891,690	+27%	+$64.8M	0.46%	39
2025 Q3	$199M	Buy	3,246,525 +800,567	+33%	+$41.7M	0.31%	58
2025 Q2	$119M	Sell	2,445,958 -167,238	-6%	-$7.94M	0.2%	100
2025 Q1	$133M	Sell	2,613,196 -673,533	-20%	-$33.6M	0.26%	69
2024 Q4	$148M	Buy	+3,286,729	New	+$141M	0.23%	61
2022 Q1	–	Sell	-75,001	Closed	-$2.99M	–	1864
2021 Q4	$2.99M	Buy	+75,001	New	+$2.87M	﹤0.01%	732

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Toronto Dominion Bank's PTCT Position: Q2 2026 in Review

Toronto Dominion Bank reduced its PTC Therapeutics (PTCT) stake by 28% in Q2 2026, selling an estimated $62.1M and leaving 2,165,846 shares worth $177M. The position accounts for 0.2% of the portfolio, ranked #96.

Toronto Dominion Bank first reported a position in PTCT in Q4 2021 and has held it in 8 quarters since. The position peaked at $314M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Toronto Dominion Bank held 2,165,846 shares of PTC Therapeutics worth $177M as of Q2 2026.
Toronto Dominion Bank sold 860,117 PTC Therapeutics shares in Q2 2026, an estimated $62.1M.
PTC Therapeutics made up 0.2% of Toronto Dominion Bank's portfolio in Q2 2026, its #96 holding.
Toronto Dominion Bank first reported a position in PTC Therapeutics in Q4 2021 and has held it in 8 quarters since.
Toronto Dominion Bank's PTC Therapeutics position peaked at $314M in Q4 2025.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.